Table 3 Adherence, log book completion rates, adverse events (total single events reported over 6Â weeks), use of rescue medication (total single events reported over 6Â weeks), and use of co-interventions
|  | Total group (N = 23) | Foot orthoses (n = 12) | Flat inserts (n = 11) |
|---|---|---|---|
Adherence (hours/week)* | 37.2 (9.8) | 37.8 (9.3) | 35.6 (11.6) |
Completion of daily log book, n (%) | 18 (72.0) | 10 (83.3) | 8 (72.2) |
Adverse events, n (%) | 17 (73.9) | 11 (64.7) | 6 (35.3) |
 Arch irritation/pain | 9 (16.1) | 8 (66.7) | 1 (9.1) |
 Back pain | 5 (8.9) | 3 (25.0) | 2 (18.2) |
 Hip pain | 4 (7.1) | 3 (25.0) | 1 (9.1) |
 Knee pain | 6 (10.7) | 4 (33.3) | 2 (18.2) |
 Tightness in footwear/shoe fit issues | 9 (16.1) | 5 (41.4) | 4 (36.4) |
 General foot discomfort/ache | 8 (14.3) | 7 (58.3) | 1 (9.1) |
 Rubbing | 1 (1.8) | 0 (0.0) | 1 (9.1) |
 Too firm | 3 (5.4) | 2 (16.7) | 1 (9.1) |
 Tired feet | 1 (1.8) | 0 (0.0) | 1 (9.1) |
 Discomfort/rubbing around MTPJ/toe region | 8 (14.3) | 6 (50.0) | 2 (18.2) |
 Other (e.g. heel pain, shin pain) | 2 (3.6) | 0 (0.0) | 2 (18.2) |
Total | 56 (100.0) | 38 (67.9) | 18 (32.1) |
Rescue medication, n (%) | |||
 Paracetamol 665 mg | 3 (5.4) | 0 (0.0) | 3 (27.3) |
 Paracetamol 500 mg | 1 (1.8) | 1 (8.3) | 0 (0.0) |
 Voltaren (diclofenac sodium) | 2 (3.6) | 1 (8.3) | 1 (9.1) |
 Celebrex (celecoxib) | 2 (3.6) | 0 (0.0) | 2 (18.2) |
 Difflam (3% benzydamine hydrochloride topical cream) | 1 (1.8) | 0 (0.0) | 1 (9.1) |
Total | 9 (100.0) | 2 (22.2) | 7 (77.8) |
Co-interventions, n (%) | |||
 Osteopathy | 1 (4.0) | 0 (0.0) | 1 (9.1) |
 Knee exercises/stretches | 2 (8.0) | 0 (0.0) | 2 (18.2) |
 Self-massage | 1 (4.0) | 1 (8.3) | 0 (0.0) |
Total | 4 (100.0) | 1 (25.0) | 3 (75.0) |